{"id":"https://openalex.org/W2005124832","doi":"https://doi.org/10.1016/j.jalz.2010.05.1950","title":"P3\u2010407: Inhibition of Glutaminyl Cyclase: Pharmacology and steps towards clinical development","display_name":"P3\u2010407: Inhibition of Glutaminyl Cyclase: Pharmacology and steps towards clinical development","publication_year":2010,"publication_date":"2010-07-01","ids":{"openalex":"https://openalex.org/W2005124832","doi":"https://doi.org/10.1016/j.jalz.2010.05.1950","mag":"2005124832"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2010.05.1950","doi":"https://doi.org/10.1016/j.jalz.2010.05.1950","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2010.05.1950","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102711941","display_name":"Hans\u2010Ulrich Demuth","orcid":"https://orcid.org/0000-0003-3505-6795","observed_orcids":["https://orcid.org/0000-0003-3505-6795"]},"institutions":[{"id":"https://openalex.org/I4210144058","display_name":"Probiodrug (Germany)","ror":"https://ror.org/03p4y9t51","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210144058"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hans-Ulrich Demuth","raw_affiliation_strings":["Probiodrug AG, Halle(Saale), Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Probiodrug AG, Halle(Saale), Germany","institution_ids":["https://openalex.org/I4210144058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064065407","display_name":"Holger Cynis","orcid":"https://orcid.org/0000-0001-6655-7539","observed_orcids":["https://orcid.org/0000-0001-6655-7539"]},"institutions":[{"id":"https://openalex.org/I4210144058","display_name":"Probiodrug (Germany)","ror":"https://ror.org/03p4y9t51","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210144058"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Holger Cynis","raw_affiliation_strings":["Probiodrug AG, Halle(Saale), Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Probiodrug AG, Halle(Saale), Germany","institution_ids":["https://openalex.org/I4210144058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066384320","display_name":"Anca Alexandru","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099772","display_name":"Ingenium (Germany)","ror":"https://ror.org/00wvsjr52","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210099772"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Anca Alexandru","raw_affiliation_strings":["Ingenium Pharmaceuticals GmbH, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ingenium Pharmaceuticals GmbH, Martinsried, Germany","institution_ids":["https://openalex.org/I4210099772"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034364271","display_name":"Wolfgang Jagla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099772","display_name":"Ingenium (Germany)","ror":"https://ror.org/00wvsjr52","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210099772"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Wolfgang Jagla","raw_affiliation_strings":["Ingenium Pharmaceuticals GmbH, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ingenium Pharmaceuticals GmbH, Martinsried, Germany","institution_ids":["https://openalex.org/I4210099772"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000192634","display_name":"Sigrid Graubner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099772","display_name":"Ingenium (Germany)","ror":"https://ror.org/00wvsjr52","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210099772"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sigrid Graubner","raw_affiliation_strings":["Ingenium Pharmaceuticals GmbH, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ingenium Pharmaceuticals GmbH, Martinsried, Germany","institution_ids":["https://openalex.org/I4210099772"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046878554","display_name":"Stephan von H\u00f6rsten","orcid":"https://orcid.org/0000-0001-6409-0664","observed_orcids":["https://orcid.org/0000-0001-6409-0664"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stephan v. Hoersten","raw_affiliation_strings":["Franz-Penzoldt-Center, University of Erlangen, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Franz-Penzoldt-Center, University of Erlangen, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101728684","display_name":"Stephan Schilling","orcid":"https://orcid.org/0000-0002-0233-4763","observed_orcids":["https://orcid.org/0000-0002-0233-4763"]},"institutions":[{"id":"https://openalex.org/I4210144058","display_name":"Probiodrug (Germany)","ror":"https://ror.org/03p4y9t51","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210144058"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stephan Schilling","raw_affiliation_strings":["Probiodrug AG, Halle(Saale), Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Probiodrug AG, Halle(Saale), Germany","institution_ids":["https://openalex.org/I4210144058"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.09311741,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"6","issue":"4S_Part_19","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C87753298","wikidata":"https://www.wikidata.org/wiki/Q17157137","display_name":"Neuroinflammation","level":3,"score":0.8059009909629822},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.6999624967575073},{"id":"https://openalex.org/C141035611","wikidata":"https://www.wikidata.org/wiki/Q5532934","display_name":"Genetically modified mouse","level":4,"score":0.5345102548599243},{"id":"https://openalex.org/C2776156579","wikidata":"https://www.wikidata.org/wiki/Q417667","display_name":"Amyloid beta","level":3,"score":0.48531049489974976},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4712168276309967},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4488803744316101},{"id":"https://openalex.org/C102230213","wikidata":"https://www.wikidata.org/wiki/Q430117","display_name":"Transgene","level":3,"score":0.4414272606372833},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.43097764253616333},{"id":"https://openalex.org/C102747710","wikidata":"https://www.wikidata.org/wiki/Q824237","display_name":"Endosome","level":3,"score":0.4236089289188385},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4189664125442505},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.37078768014907837},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3251626193523407},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2728005051612854},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2712247669696808},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2527657151222229},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.232242614030838},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21577084064483643},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.08970251679420471},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.07187587022781372},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2010.05.1950","doi":"https://doi.org/10.1016/j.jalz.2010.05.1950","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2010.05.1950","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2031241201","https://openalex.org/W2070895050","https://openalex.org/W2086927095","https://openalex.org/W2079479452","https://openalex.org/W2334708421","https://openalex.org/W1982724245","https://openalex.org/W1974073967","https://openalex.org/W1990632702","https://openalex.org/W2162756909","https://openalex.org/W1964747897"],"abstract_inverted_index":{"We":[0,133,160],"have":[1,134],"validated":[2],"that":[3],"Glutaminyl":[4],"Cyclase":[5],"(QC)":[6],"facilitates":[7],"pyroglutamate-formation":[8],"(pGlu)":[9],"from":[10,47],"N-terminal":[11,50],"glutamate,":[12],"which":[13,320],"promotes":[14],"aggregation":[15],"and":[16,56,72,99,120,165,218,275,278,304],"toxicity":[17,303],"of":[18,49,74,93,109,118,123,130,147,214,222,226,237,249,263,272,284,290,293,306],"the":[19,44,115,127,145,153,202,229,235,270,280,323],"pGlu":[20],"beta-amyloid":[21],"peptides":[22],"(pGlu-A\u03b2)":[23],"in":[24,54,67,77,85,126,157,210,295],"neurodegeneration.":[25],"In":[26,101,195,251],"addition,":[27],"we":[28,176,255,313],"found":[29,125],"this":[30,104],"modification":[31],"also":[32,256],"relevant":[33],"for":[34,59,299],"inflammatory":[35],"chemokines":[36],"such":[37,62,91,113],"as":[38,63,114,169,171,187,189],"monocyte-chemoattractant":[39],"protein-1":[40],"(MCP-1,":[41],"CCL-2).":[42],"Here,":[43],"pGlu-residue":[45],"originates":[46],"cyclization":[48],"glutamine":[51],"by":[52,193,282],"QC":[53],"vivo":[55,296],"is":[57,243],"responsible":[58],"biological":[60],"activity":[61],"immune":[64,70,307],"cell":[65,208],"invasion":[66],"overreacting":[68],"peripheral":[69],"response":[71],"recruitment":[73],"glial":[75],"cells":[76],"neuroinflammation.":[78,100],"However,":[79],"modeling":[80],"Alzheimer's":[81,266],"disease":[82],"(AD)-like":[83],"phenotypes":[84],"mice":[86],"still":[87],"does":[88],"not":[89],"mimic":[90],"features":[92],"AD":[94,131],"including":[95],"early":[96],"neuronal":[97,148,291],"loss":[98,209],"these":[102,223,311],"models":[103,139],"may":[105],"indicate":[106],"a":[107,178,211,259,300,315],"lack":[108],"some":[110],"pathogenic":[111],"factors":[112],"high":[116],"content":[117],"N-truncated":[119],"pGlu-modified":[121],"forms":[122],"A\u03b2":[124,219],"amyloid":[128],"deposits":[129],"patients.":[132],"developed":[135],"novel":[136,179],"transgenic":[137,204],"mouse":[138],"specifically":[140,143],"generating":[141],"pGlu-A\u03b2":[142,190,200,238,294,302],"studying":[144],"effects":[146],"pGlu-A\u03b2,":[149],"expressed":[150],"either":[151],"within":[152],"secretory":[154],"pathway":[155],"or":[156],"lysosomal/endosomal":[158],"vesicles.":[159],"used":[161],"different":[162],"high-sensitivity":[163],"AD-":[164],"neurodegeneration":[166],"staining":[167],"methods":[168],"well":[170,188],"immunohistochemistry.":[172],"For":[173],"behavioral":[174,181,231],"screening":[175],"applied":[177],"comprehensive":[180],"phenotyping":[182],"battery.":[183],"Total":[184],"Abeta":[185],"load":[186],"were":[191],"analyzed":[192],"ELISA.":[194],"addition":[196],"to":[197,234],"showing":[198],"significant":[199],"levels,":[201],"new":[203],"animals":[205],"display":[206],"age-dependent":[207],"time":[212],"frame":[213],"4":[215],"month,":[216],"gliosis":[217],"deposits,":[220],"all":[221],"being":[224],"hallmarks":[225],"AD.":[227],"Also":[228],"neurodegenerative":[230],"phenotype":[232],"corresponds":[233],"onset":[236],"expression.":[239],"The":[240,288],"CA1-neuronal":[241],"layer":[242],"completely":[244],"lost":[245],"at":[246],"month":[247],"5":[248],"age.":[250],"additional":[252],"pharmacological":[253],"experiments":[254],"could":[257],"demonstrate":[258],"potential":[260],"dual":[261],"function":[262],"QC-inhibitors":[264],"targeting":[265],"disease,":[267],"reducing":[268],"both":[269],"amount":[271],"highly":[273],"toxic":[274],"amyloidogenic":[276],"pGlu-peptides":[277],"ameliorating":[279],"neuroinflammation":[281],"suppression":[283],"biologically":[285],"active":[286],"MCP-1.":[287],"findings":[289],"expression":[292],"provide":[297],"evidence":[298],"direct":[301],"stimulation":[305],"response.":[308],"Based":[309],"on":[310],"data,":[312],"launched":[314],"broad":[316],"QC-inhibitor":[317],"development":[318,326],"program":[319],"has":[321],"approached":[322],"regulatory":[324],"drug":[325],"phase.":[327]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}